{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:01:33Z","timestamp":1761253293802,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherche sur le SIDA et les h\u00e9patites virales","doi-asserted-by":"crossref","award":["12279"],"award-info":[{"award-number":["12279"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3282-7","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T14:38:11Z","timestamp":1533566291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study"],"prefix":"10.1186","volume":"18","author":[{"name":"for the MAGGSEN Cohort Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-7107","authenticated-orcid":false,"given":"Cecile","family":"Cames","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aissatou","family":"Ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Mbodj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baly","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndeye-Fatou","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Msellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngagne","family":"Mbaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haby","family":"Sy Signate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminata","family":"Diack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"issue":"18","key":"3282_CR1","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","volume":"15","author":"S Duran","year":"2001","unstructured":"Duran S, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS. 2001;15(18):2441\u20134.","journal-title":"AIDS"},{"issue":"2","key":"3282_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","volume":"40","author":"M Beregszaszi","year":"2005","unstructured":"Beregszaszi M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr. 2005;40(2):161\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"3282_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/QAI.0b013e31824330cb","volume":"59","author":"N Alam","year":"2012","unstructured":"Alam N, et al. Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors. J Acquir Immune Defic Syndr. 2012;59(3):314\u201324.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"3282_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","volume":"32","author":"A Vigano","year":"2003","unstructured":"Vigano A, et al. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr. 2003;32(5):482\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3282_CR5","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","volume":"114","author":"P Taylor","year":"2004","unstructured":"Taylor P, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics. 2004;114(2):e235\u201342.","journal-title":"Pediatrics"},{"issue":"14","key":"3282_CR6","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","volume":"14","author":"D Jaquet","year":"2000","unstructured":"Jaquet D, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14(14):2123\u20138.","journal-title":"AIDS"},{"issue":"10","key":"3282_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","volume":"18","author":"European Paediatric Lipodystrophy Group","year":"2004","unstructured":"European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18(10):1443\u201351.","journal-title":"AIDS"},{"issue":"1","key":"3282_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00042560-200105010-00005","volume":"27","author":"SM Arpadi","year":"2001","unstructured":"Arpadi SM, et al. Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr. 2001;27(1):30\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3282_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00431-006-0193-1","volume":"166","author":"L Ene","year":"2007","unstructured":"Ene L, et al. Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study. Eur J Pediatr. 2007;166(1):13\u201321.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"3282_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","volume":"25","author":"K Hartman","year":"2006","unstructured":"Hartman K, et al. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Pediatr Infect Dis J. 2006;25(5):427\u201331.","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Suppl","key":"3282_CR11","first-page":"S5","volume":"13","author":"DP Kotler","year":"2003","unstructured":"Kotler DP. HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: etiology and pathogenesis. AIDS Read. 2003;13(4 Suppl):S5\u20139.","journal-title":"AIDS Read"},{"issue":"9130","key":"3282_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(05)60719-2","volume":"352","author":"E Martinez","year":"1998","unstructured":"Martinez E, Gatell J. Metabolic abnormalities and use of HIV-1 protease inhibitors. Lancet. 1998;352(9130):821\u20132.","journal-title":"Lancet"},{"issue":"2","key":"3282_CR13","doi-asserted-by":"publisher","first-page":"17427","DOI":"10.7448\/IAS.15.2.17427","volume":"15","author":"T Piloya","year":"2012","unstructured":"Piloya T, et al. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study. J Int AIDS Soc. 2012;15(2):17427.","journal-title":"J Int AIDS Soc"},{"issue":"14","key":"3282_CR14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","volume":"22","author":"B Zanone Poma","year":"2008","unstructured":"Zanone Poma B, et al. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. AIDS. 2008;22(14):1769\u201378.","journal-title":"AIDS"},{"issue":"1","key":"3282_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/INF.0b013e3182755a34","volume":"32","author":"GD Kinabo","year":"2013","unstructured":"Kinabo GD, et al. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy. Pediatr Infect Dis J. 2013;32(1):39\u201344.","journal-title":"Pediatr Infect Dis J"},{"key":"3282_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2431-12-183","volume":"12","author":"S Innes","year":"2012","unstructured":"Innes S, et al. High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study. BMC Pediatr. 2012;12:183.","journal-title":"BMC Pediatr"},{"key":"3282_CR17","volume-title":"Recommendations for a public health approach","author":"WHO, Antiretroviral therapy for HIV infection in adults and adolescents","year":"2006","unstructured":"WHO, Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. Geneva: World Health Organization; 2006."},{"key":"3282_CR18","unstructured":"UNAIDS. Country factsheets Senegal. 2016 [cited 2018 05\/05\/2018]; Available from: http:\/\/www.unaids.org\/fr\/regionscountries\/countries\/senegal ."},{"key":"3282_CR19","doi-asserted-by":"crossref","unstructured":"Cames C, et al. Risk Factors for Growth Retardation in HIV-Infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort Study. Pediatr Infect Dis J. 2017;36(4):e87\u2013e92.","DOI":"10.1097\/INF.0000000000001454"},{"key":"3282_CR20","unstructured":"WHO. Child growth standards: WHO Anthro (version 3.2.2, January 2011) and macros. 2006 [cited 2012 07\/30\/2012]; Available from: http:\/\/www.who.int\/childgrowth\/software\/en\/ ."},{"key":"3282_CR21","unstructured":"WHO. Growth reference 5\u201319 years: WHO Anthro Plus software and macros. 2007 [cited 2012 07\/30\/2012]; Available from: http:\/\/www.who.int\/growthref\/tools\/en\/ ."},{"issue":"9359","key":"3282_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361(9359):726\u201335.","journal-title":"Lancet"},{"key":"3282_CR23","volume-title":"Growth at adolescence","author":"JM Tanner","year":"1962","unstructured":"Tanner JM. Growth at adolescence. Oxford: Blackwell Scientific; 1962. 325 p."},{"issue":"5","key":"3282_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1086\/655765","volume":"51","author":"E Hammond","year":"2010","unstructured":"Hammond E, McKinnon E, Nolan D. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. Clin Infect Dis. 2010;51(5):591\u20139.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3282_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","volume":"14","author":"SA Mallal","year":"2000","unstructured":"Mallal SA, et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14(10):1309\u201316.","journal-title":"AIDS"},{"issue":"5","key":"3282_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/14656566.8.5.679","volume":"8","author":"A Hill","year":"2007","unstructured":"Hill A, et al. Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother. 2007;8(5):679\u201388.","journal-title":"Expert Opin Pharmacother"},{"key":"3282_CR27","unstructured":"WHO, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2013: Geneva."},{"key":"3282_CR28","doi-asserted-by":"crossref","unstructured":"Mulenga V, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2015;","DOI":"10.1016\/S1473-3099(15)00319-9"},{"key":"3282_CR29","volume-title":"Antiretroviral medicines in low- and middle-income countries: forecasts of global and regional demand for 2013\u20132016","author":"WHO","year":"2014","unstructured":"WHO. Antiretroviral medicines in low- and middle-income countries: forecasts of global and regional demand for 2013\u20132016. Geneva: World Health Organization; 2014."},{"issue":"5","key":"3282_CR30","doi-asserted-by":"publisher","first-page":"e63623","DOI":"10.1371\/journal.pone.0063623","volume":"8","author":"R de Waal","year":"2013","unstructured":"de Waal R, Cohen K, Maartens G. Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One. 2013;8(5):e63623.","journal-title":"PLoS One"},{"issue":"2","key":"3282_CR31","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/INF.0000000000000491","volume":"34","author":"M Bwakura-Dangarembizi","year":"2015","unstructured":"Bwakura-Dangarembizi M, et al. Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. Pediatr Infect Dis J. 2015;34(2):e23\u201331.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"3282_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/INF.0b013e31823f0e11","volume":"31","author":"L Aurpibul","year":"2012","unstructured":"Aurpibul L, et al. Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Pediatr Infect Dis J. 2012;31(4):384\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"3282_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1258\/ijsa.2011.011348","volume":"23","author":"N Sawawiboon","year":"2012","unstructured":"Sawawiboon N, et al. Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine. Int J STD AIDS. 2012;23(7):497\u2013501.","journal-title":"Int J STD AIDS"},{"issue":"9119","key":"3282_CR34","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr A, et al. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351(9119):1881\u20133.","journal-title":"Lancet"},{"issue":"16","key":"3282_CR35","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","volume":"13","author":"P Domingo","year":"1999","unstructured":"Domingo P, et al. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS. 1999;13(16):2261\u20137.","journal-title":"AIDS"},{"issue":"13","key":"3282_CR36","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/QAD.0b013e328270356a","volume":"21","author":"TT Brown","year":"2007","unstructured":"Brown TT, et al. Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS. 2007;21(13):1731\u20138.","journal-title":"AIDS"},{"issue":"1","key":"3282_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/01.qai.0000138420.38995.86","volume":"37","author":"PE Sax","year":"2004","unstructured":"Sax PE, Kumar P. Tolerability and safety of HIV protease inhibitors in adults. J Acquir Immune Defic Syndr. 2004;37(1):1111\u201324.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"3282_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/archdischild-2012-302633","volume":"98","author":"S Arpadi","year":"2013","unstructured":"Arpadi S, et al. Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arch Dis Child. 2013;98(4):258\u201364.","journal-title":"Arch Dis Child"},{"issue":"7","key":"3282_CR39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1017\/S1368980014001591","volume":"18","author":"LC Dos Reis","year":"2014","unstructured":"Dos Reis LC, et al. Anthropometry and body composition of vertically HIV-infected children and adolescents under therapy with and without protease inhibitors. Public Health Nutr. 2014;18(7):1255\u201361.","journal-title":"Public Health Nutr"},{"issue":"8","key":"3282_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1258\/ijsa.2011.010516","volume":"22","author":"LC Ramalho","year":"2011","unstructured":"Ramalho LC, et al. Abnormalities in body composition and nutritional status in HIV-infected children and adolescents on antiretroviral therapy. Int J STD AIDS. 2011;22(8):453\u20136.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"3282_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAI.0000000000001484","volume":"76","author":"J Jesson","year":"2017","unstructured":"Jesson J, et al. Evaluation of a Nutritional Support Intervention in Malnourished HIV-Infected Children in Bamako, Mali. J Acquir Immune Defic Syndr. 2017;76(2):149\u201357.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3282_CR42","doi-asserted-by":"crossref","unstructured":"Cames C, et al. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Food Nutr Bull. 2017;38(1):27\u201336.","DOI":"10.1177\/0379572116679053"},{"issue":"12","key":"3282_CR43","doi-asserted-by":"publisher","first-page":"e84328","DOI":"10.1371\/journal.pone.0084328","volume":"8","author":"M Fiorentino","year":"2013","unstructured":"Fiorentino M, et al. Anthropometric and micronutrient status of school-children in an urban West Africa setting: a cross-sectional study in Dakar (Senegal). PLoS One. 2013;8(12):e84328.","journal-title":"PLoS One"},{"issue":"8","key":"3282_CR44","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","volume":"12","author":"L Aurpibul","year":"2007","unstructured":"Aurpibul L, et al. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther. 2007;12(8):1247\u201354.","journal-title":"Antivir Ther"},{"issue":"5 Suppl","key":"3282_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/ajcn\/35.5.1169","volume":"35","author":"SJ Fomon","year":"1982","unstructured":"Fomon SJ, et al. Body composition of reference children from birth to age 10 years. Am J Clin Nutr. 1982;35(5 Suppl):1169\u201375.","journal-title":"Am J Clin Nutr"},{"key":"3282_CR46","first-page":"76","volume-title":"Body composition during adolescence, in Body composition measurements in infants and children - Report of the 98th Ross Conference on Pediatric Research","author":"F Haschke","year":"1989","unstructured":"Haschke F. In: Klish WJ, Kretchmer N, editors. Body composition during adolescence, in Body composition measurements in infants and children - Report of the 98th Ross Conference on Pediatric Research. Colombus Ohio: Ross Laboratories; 1989. p. 76\u201382."},{"issue":"13","key":"3282_CR47","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","volume":"18","author":"GA McComsey","year":"2004","unstructured":"McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18(13):1753\u201368.","journal-title":"AIDS"},{"issue":"1","key":"3282_CR48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0000000000000927","volume":"35","author":"S Innes","year":"2016","unstructured":"Innes S, et al. High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy. Pediatr Infect Dis J. 2016;35(1):e1\u20137.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3282-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T20:23:34Z","timestamp":1661718214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3282"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3282-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics clearance for the cohort study was given by the Ethics and Regulatory Committees in Senegal (Ministry of Health) and the Ethics Committee of the Institute of Research for Development in France. All parents or legal guardians provided written informed consent on behalf of their children.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"374"}}